The roadmap for 3D Pharma Printing towards clinical applications
As a new technology for the pharmaceutical industry, we foresee that 3D Printing will follow its growth path according to the following logical steps. Starting in the research laboratories (universities) with first applications in university hospitals. With that knowledge gained the next step will be the top clinical hospitals. By that time the experience both in production and compounding will reach such a level that the general hospitals and community pharmacies can start using it on a larger scale. Dependent on their level of innovation, compounding companies will join the 3D Pharma Printing bandwagon somewhere during this process.
This whole process will take some time, as legislation and certification will play an important role, next to the further development of the applied technologies.
It is important to realise that this technology offers new applications which impact the prescribing role of physicians. This technology goes beyond the ‘regular’ prescription protocols, so it is of paramount importance that physicians and general practitioners need to learn about the applications of 3D Pharma printing as well, next to the pharmacists off course.
Topics of the conference
- Faster pre-clinical evaluation of new drugs
- New formulations for improved drug delivery
- Patient-centric design / personalised medicine
- Local manufacture / Simplified logistics
- Reduced wastage
- Regulation / Certification
- Safety / Quality control
The first edition of this conference for the pharmaceutical industry took place in 2017. Since then the conference took place on an annual base.
Have a look at other conferences organised by Jakajima over the years.